Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Operating Leases (2018 - 2025)

Historic Operating Leases for Dr Reddys Laboratories (RDY) over the last 8 years, with Q4 2025 value amounting to $2.2 billion.

  • Dr Reddys Laboratories' Operating Leases changed N/A to $2.2 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $2.2 billion, marking a year-over-year change of. This contributed to the annual value of $1.9 billion for FY2025, which is 719997.84% up from last year.
  • According to the latest figures from Q4 2025, Dr Reddys Laboratories' Operating Leases is $2.2 billion.
  • In the past 5 years, Dr Reddys Laboratories' Operating Leases ranged from a high of $2.2 billion in Q4 2025 and a low of $1470.7 during Q2 2022
  • Over the past 5 years, Dr Reddys Laboratories' median Operating Leases value was $1.4 billion (recorded in 2021), while the average stood at $1.1 billion.
  • Per our database at Business Quant, Dr Reddys Laboratories' Operating Leases tumbled by 9999.99% in 2022 and then skyrocketed by 11967863924.18% in 2023.
  • Over the past 5 years, Dr Reddys Laboratories' Operating Leases (Quarter) stood at $1.4 billion in 2021, then grew by 13.94% to $1.6 billion in 2022, then rose by 11.14% to $1.8 billion in 2023, then crashed by 98.5% to $26.4 million in 2024, then soared by 8192.62% to $2.2 billion in 2025.
  • Its Operating Leases stands at $2.2 billion for Q4 2025, versus $1.9 billion for Q1 2025 and $26.4 million for Q1 2024.